Haemonetics Corporation (HAE)

Debt-to-assets ratio

		Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Long-term debt	US$ in thousands	797,564	754,102	559,441	690,592	305,513
Total assets	US$ in thousands	2,195,590	1,934,820	1,859,730	1,819,920	1,267,110
Debt-to-assets ratio		0.36	0.39	0.30	0.38	0.24

March 31, 2024 calculation

Debt-to-assets ratio = Long-term debt ÷ Total assets
= $797,564K ÷ $2,195,590K
= 0.36

The debt-to-assets ratio for Haemonetics Corporation has fluctuated over the past five years, ranging from 0.24 to 0.39. This ratio indicates the proportion of the company's assets financed by debt. A lower ratio suggests a lower reliance on debt financing, while a higher ratio indicates a higher level of debt relative to assets.

In 2024, the debt-to-assets ratio decreased to 0.36 from 0.39 in 2023, which could imply a reduction in debt relative to assets. However, it still remains above the 2022 level of 0.30. The company's ratio in 2021 was 0.38 and in 2020 it was 0.24.

The fluctuations in the debt-to-assets ratio may reflect changes in the company's capital structure and financing decisions. Investors and creditors typically analyze this ratio to assess the financial risk associated with the company's debt levels. Haemonetics Corporation's management may need to carefully monitor and manage its debt levels to maintain a balance between leveraging debt for growth opportunities and controlling financial risks.